Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-26.

06th October, 2026 The Dy. General Manager (Listing Dept.) T h e M a nager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., E x c h a n g e Plaza, 5th Floor, 1st Floor, New Trading Ring, P l o t N o . C/1, G. Block, P. J. Towers, Dalal Street, Fort, B a n d r a - Kurla Complex, Bandra (E), Mumbai - 400 001 M u m b a i – 400 051 (BSE Scrip Code: 500420) ( N S E S crip Code: TORNTPHARM) Dear Sir, Sub.: Intimation of the date of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that a meeting of the Board of Directors will be held on Friday, 23-Oct-26, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-26. Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com